Equillium, Inc. (EQ)
2.23
-0.02
(-0.89%)
USD |
NASDAQ |
Sep 03, 10:42
Equillium Research and Development Expense (TTM) : 8.577M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.577M |
| March 31, 2026 | 9.911M |
| December 31, 2025 | 12.84M |
| September 30, 2025 | 18.62M |
| June 30, 2025 | 26.88M |
| March 31, 2025 | 33.61M |
| December 31, 2024 | 37.43M |
| September 30, 2024 | 39.30M |
| June 30, 2024 | 38.71M |
| March 31, 2024 | 37.51M |
| December 31, 2023 | 37.04M |
| September 30, 2023 | 36.38M |
| June 30, 2023 | 36.18M |
| March 31, 2023 | 36.06M |
| December 31, 2022 | 60.60M |
| September 30, 2022 | 59.62M |
| Date | Value |
|---|---|
| June 30, 2022 | 57.81M |
| March 31, 2022 | 54.31M |
| December 31, 2021 | 26.38M |
| September 30, 2021 | 25.40M |
| June 30, 2021 | 22.65M |
| March 31, 2021 | 20.56M |
| December 31, 2020 | 19.38M |
| September 30, 2020 | 18.27M |
| June 30, 2020 | 18.23M |
| March 31, 2020 | 18.59M |
| December 31, 2019 | 17.64M |
| September 30, 2019 | 14.71M |
| June 30, 2019 | 11.75M |
| March 31, 2019 | 8.162M |
| December 31, 2018 | 4.453M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Fortress Biotech, Inc. | 1.186M |
| Cue Biopharma, Inc. | 76.97M |
| Legend Biotech Corp. | 397.18M |
| Dianthus Therapeutics, Inc. | 175.60M |